Collagenase clostridium histolyticum is under clinical development by Endo International and currently in Phase III for Unspecified Musculoskeletal Disorders.

Methods for preparing proteinase free of collagenolytic activity have been described 1; but collagenase free of other proteolytic activity has never been obtained.